Executive Board Partner

Diabetes Reversal Group® (DRG) is a digital health and telemedicine company focused on Type 2 diabetes and metabolic health.

Founded in 2009, DRG has supported more than 10,000 patients and generated more than $38 million in revenue, including a previous annual revenue high of $11.7 million.

The company's methodology is protected by U.S. Patent No. 10,765,318 and combines nutrition, exercise, health coaching, education, community support and nutritional supplementation.

DRG previously expanded through a network of 17 physical clinics before transitioning to a fully digital and telemedicine model.

The company is now focused on scaling through self-insured employer partnerships, healthcare-practitioner licensing, direct-to-consumer channels, technology development and international expansion.

As part of this next phase, DRG is selectively expanding its Executive Board Partner program.

DRG is seeking a limited number of senior executives, healthcare leaders, operators and investors to participate as Executive Board Partners.

The role is distinct from formal Board membership and is designed for individuals who can contribute strategic perspective, relevant relationships and long-term ownership alignment.

Executive Board Partners may contribute across areas including commercial growth, employer healthcare and benefits, physician and provider networks, digital health and telemedicine, healthcare distribution, strategic partnerships, consumer health, technology, international expansion, capital strategy and governance.

Engagement is strategic and periodic rather than operational, with DRG seeking individuals whose experience and relationships complement the existing leadership team.

DRG combines the operating history of an established healthcare business with the scalability of a digital health model.

After more than 17 years of developing its approach, serving patients and building its commercial infrastructure, the company's next phase is focused on distribution, technology and scale.

DRG is developing multiple routes to market through employers, healthcare practitioners, strategic partners and international markets.

A key technology priority is the planned integration of AI into the DRG patient app, with the objective of increasing automation, enhancing patient support and enabling the company to serve a larger patient population more efficiently.

Growth capital is being deployed across marketing, technology and operations to support this expansion.

This is an equity-based position aligned with ownership participation in the company and is not a cash-compensated role.

DRG is looking for Executive Board Partners who believe strategic contribution and ownership alignment should operate together.

Candidates should be accredited investors and comfortable exploring ownership participation where there is mutual alignment following discussions with DRG leadership and appropriate due diligence.

Any potential investment would be discussed directly with company leadership and remain subject to the company's offering documentation, investor qualification requirements and applicable securities laws.

We are seeking individuals with 5+ years of senior executive, founder or board particularly across digital health, telemedicine, healthcare services, employer healthcare and benefits, population health, chronic disease management, healthcare technology, provider networks, consumer healthcare, commercialisation, strategic partnerships, enterprise growth, international expansion or private-company investing.

We are particularly interested in individuals who have helped build or scale healthcare or technology businesses, understand healthcare commercialisation and distribution, bring meaningful industry relationships, have experience developing strategic partnerships, have previously served on Boards or Advisory Boards, and can contribute strategically beyond capital.

DRG is entering a period focused on scaling an established business through a more diversified and technology-enabled commercial model.

The company is expanding its focus across employer distribution, healthcare-practitioner licensing, strategic partnerships and international opportunities while continuing to invest in its digital infrastructure and patient platform.

The planned introduction of AI into the patient app is intended to support this next stage by increasing automation and allowing DRG to scale patient support more efficiently.

Executive Board Partners will have the opportunity to contribute experience, relationships and strategic perspective during this next stage of the company's development.

Diabetes Reversal Group welcomes candidates from a wide range of professional and industry backgrounds.

The company believes different perspectives and experiences strengthen strategic decision-making and long-term company development.